Medical Devices
-
MDUFA IVD-Specific Goals (MDUFMA FDA Performance Report January 26, 2010)
MDUFA IVD-Specific Goals (as of 1/25/10)
| Item | Responsibility | Due date | Status | |
|---|---|---|---|---|
| FDA | Industry | |||
| leftover specimens guidance | X | None | Reg change likely | |
| clinical trial design issues for molecular diagnostic tests guidance | X | None | ?, we haven’t heard anything | |
| migration studies guidance | X | None | X, 1/5/09 | |
| herpes simplex virus guidance | X | CY 2008 | X, 4/3/07 | |
| enterovirus guidance | X | CY 2008 | X, 1/2/09 | |
| influenza testing guidance | X | CY 2008 | X, 2/15/08 | |
| pilot CLIA waiver/510(k) concurrent review | X | X | None | X, FY 20082 submitted; lengthened 510(k) and waiver review |
| CLIA Waiver Protocol Submission | X | None | ?, OIVD / Industry | |
| track CLIA Waiver Performance | X | Annually, & assess at EOY09 | X, IT issues, tracking manually | |
| class I exempt list | X | 11/1/07 | X, 9/22/09 submitted by industry, under FDA review | |
| class II exempt list | X | 11/1/07 | X, 9/22/09 submitted by industry, under FDA review | |
| pre-IDE review | X | X | FY 2008 | X, OIVD & Industry Surveys completed, OIVD drafting guidance |
-
-







